📝 Raaj Medisafe India Ltd — results explained
Quarter ended June 2026 (Q1 FY27)
Raaj Medisafe India Ltd reported revenue of ₹29 crore for the quarter ended June 2026 (Q1 FY27), up 86.1% from ₹16 crore in the same quarter last year, and up 17.5% sequentially over the March 2026 quarter.
Net profit rose 35.2% year-on-year to ₹2 crore, from ₹1 crore. Earnings per share (EPS) came in at ₹1.20.
Operating profit stood at ₹4 crore — an operating margin (OPM) of 13.8%, compared with 16.6% in the year-ago quarter.
Full year and trailing twelve months
For the full year FY26, Raaj Medisafe India Ltd posted revenue of ₹80 crore, a growth of 31.6% over FY25, with a net profit of ₹2 crore (down 71.3% year-on-year).
On a trailing-twelve-month (TTM) basis, revenue stands at ₹94 crore with a net profit of ₹2 crore.
Valuation snapshot
At the current price of ₹101.99, 524502 has a market capitalisation of ₹167 crore and a trailing P/E of about 70.8.
Within the Packaging industry, it is the 25th-largest of the 80 companies we track by market value.
Shareholding pattern
As of Jun 2026, promoters held 59.08%, public shareholders 40.92% of Raaj Medisafe India Ltd.
Promoter holding slipped from 73.80% to 59.08% over the latest period.